Description
A GLP-1 receptor agonist that mimics naturally occurring incretin hormones, making it a valuable tool for metabolic and endocrine research.
Key Benefits: Supports research into appetite regulation, glucose homeostasis, gastric emptying, metabolic function, and energy balance.
Semaglutide is typically administered under medical supervision, with dosing protocols tailored to individual health goals and clinical evaluation.




